BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1141 related articles for article (PubMed ID: 29710519)

  • 1. Effects of shenling baizhu powder herbal formula on intestinal microbiota in high-fat diet-induced NAFLD rats.
    Zhang Y; Tang K; Deng Y; Chen R; Liang S; Xie H; He Y; Chen Y; Yang Q
    Biomed Pharmacother; 2018 Jun; 102():1025-1036. PubMed ID: 29710519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic protective effects of Shenling Baizhu powder, a herbal compound, against inflammatory damage via TLR4/NLRP3 signalling pathway in rats with nonalcoholic fatty liver disease.
    Pan MX; Zheng CY; Deng YJ; Tang KR; Nie H; Xie JQ; Liu DD; Tu GF; Yang QH; Zhang YP
    J Integr Med; 2021 Sep; 19(5):428-438. PubMed ID: 34426178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Shenling Baizhu powder on intestinal microflora metabolites and liver mitochondrial energy metabolism in nonalcoholic fatty liver mice.
    Yao Z; Guo J; Du B; Hong L; Zhu Y; Feng X; Hou Y; Shi A
    Front Microbiol; 2023; 14():1147067. PubMed ID: 37538846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural modulation of gut microbiota during alleviation of non-alcoholic fatty liver disease with Gynostemma pentaphyllum in rats.
    Shen SH; Zhong TY; Peng C; Fang J; Lv B
    BMC Complement Med Ther; 2020 Feb; 20(1):34. PubMed ID: 32024509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of the Gut Microbiota in Rats by Hugan Qingzhi Tablets during the Treatment of High-Fat-Diet-Induced Nonalcoholic Fatty Liver Disease.
    Tang W; Yao X; Xia F; Yang M; Chen Z; Zhou B; Liu Q
    Oxid Med Cell Longev; 2018; 2018():7261619. PubMed ID: 30671174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory effect of a Chinese herbal medicine formula on non-alcoholic fatty liver disease.
    Yang JM; Sun Y; Wang M; Zhang XL; Zhang SJ; Gao YS; Chen L; Wu MY; Zhou L; Zhou YM; Wang Y; Zheng FJ; Li YH
    World J Gastroenterol; 2019 Sep; 25(34):5105-5119. PubMed ID: 31558860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Freeze-dried Si-Ni-San powder can ameliorate high fat diet-induced non-alcoholic fatty liver disease.
    Zhu F; Li YM; Feng TT; Wu Y; Zhang HX; Jin GY; Liu JP
    World J Gastroenterol; 2019 Jun; 25(24):3056-3068. PubMed ID: 31293341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-targeting therapeutic mechanisms of the Chinese herbal medicine QHD in the treatment of non-alcoholic fatty liver disease.
    Feng Q; Liu W; Baker SS; Li H; Chen C; Liu Q; Tang S; Guan L; Tsompana M; Kozielski R; Baker RD; Peng J; Liu P; Zhu R; Hu Y; Zhu L
    Oncotarget; 2017 Apr; 8(17):27820-27838. PubMed ID: 28416740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
    Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
    Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipidomic Analysis of the Protective Effects of Shenling Baizhu San on Non-Alcoholic Fatty Liver Disease in Rats.
    Deng Y; Pan M; Nie H; Zheng C; Tang K; Zhang Y; Yang Q
    Molecules; 2019 Oct; 24(21):. PubMed ID: 31683679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Shenling Baizhu Powder alleviates chronic inflammation to prevent type 2 diabetes of ZDF rats via intestinal flora].
    Zhang LJ; Zhan LB; Hang TY; Luo JT; Zhao CY
    Zhongguo Zhong Yao Za Zhi; 2022 Feb; 47(4):988-1000. PubMed ID: 35285199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Soothing Gan (Liver) and Invigorating Pi (Spleen) Recipes on TLR4-p38 MAPK Pathway in Kupffer Cells of Non-alcoholic Steatohepatitis Rats.
    Gong XW; Xu YJ; Yang QH; Liang YJ; Zhang YP; Wang GL; Li YY
    Chin J Integr Med; 2019 Mar; 25(3):216-224. PubMed ID: 29335857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Si Miao Formula attenuates non-alcoholic fatty liver disease by modulating hepatic lipid metabolism and gut microbiota.
    Han R; Qiu H; Zhong J; Zheng N; Li B; Hong Y; Ma J; Wu G; Chen L; Sheng L; Li H
    Phytomedicine; 2021 May; 85():153544. PubMed ID: 33773192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mechanism of Shenling Baizhu Powder in alleviation of ulcerative colitis in mice based on high-throughput transcriptome sequencing].
    Sun J; Jiang XJ; Wang YD; Ma KL; Li ZH; Wang TC; Wang TM; Shao J; Wang CZ
    Zhongguo Zhong Yao Za Zhi; 2022 Nov; 47(22):6155-6163. PubMed ID: 36471940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the gut microbiota with resveratrol: a demonstration of novel evidence for the management of hepatic steatosis.
    Wang P; Wang J; Li D; Ke W; Chen F; Hu X
    J Nutr Biochem; 2020 Jul; 81():108363. PubMed ID: 32388250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Luteolin alleviates non-alcoholic fatty liver disease in rats via restoration of intestinal mucosal barrier damage and microbiota imbalance involving in gut-liver axis.
    Liu X; Sun R; Li Z; Xiao R; Lv P; Sun X; Olson MA; Gong Y
    Arch Biochem Biophys; 2021 Oct; 711():109019. PubMed ID: 34478730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium butyrate attenuates high-fat diet-induced steatohepatitis in mice by improving gut microbiota and gastrointestinal barrier.
    Zhou D; Pan Q; Xin FZ; Zhang RN; He CX; Chen GY; Liu C; Chen YW; Fan JG
    World J Gastroenterol; 2017 Jan; 23(1):60-75. PubMed ID: 28104981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of different diets on intestinal microbiota and nonalcoholic fatty liver disease development.
    Liu JP; Zou WL; Chen SJ; Wei HY; Yin YN; Zou YY; Lu FG
    World J Gastroenterol; 2016 Aug; 22(32):7353-64. PubMed ID: 27621581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mussel polysaccharide α-D-glucan (MP-A) protects against non-alcoholic fatty liver disease via maintaining the homeostasis of gut microbiota and regulating related gut-liver axis signaling pathways.
    Wu J; Shao H; Zhang J; Ying Y; Cheng Y; Zhao D; Dou X; Lv H; Li S; Liu F; Ling P
    Int J Biol Macromol; 2019 Jun; 130():68-78. PubMed ID: 30797009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Red pitaya betacyanins protects from diet-induced obesity, liver steatosis and insulin resistance in association with modulation of gut microbiota in mice.
    Song H; Chu Q; Yan F; Yang Y; Han W; Zheng X
    J Gastroenterol Hepatol; 2016 Aug; 31(8):1462-9. PubMed ID: 26699443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.